NO882792L - Fremstilling og anvendelse av promotere for ekspresjon avfremmed-dna i metylotrofe bakterier. - Google Patents
Fremstilling og anvendelse av promotere for ekspresjon avfremmed-dna i metylotrofe bakterier.Info
- Publication number
- NO882792L NO882792L NO882792A NO882792A NO882792L NO 882792 L NO882792 L NO 882792L NO 882792 A NO882792 A NO 882792A NO 882792 A NO882792 A NO 882792A NO 882792 L NO882792 L NO 882792L
- Authority
- NO
- Norway
- Prior art keywords
- dna
- promoter
- coli
- fragments
- plasmid
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title claims description 9
- 241000894006 Bacteria Species 0.000 title description 3
- 239000013612 plasmid Substances 0.000 claims description 43
- 241000588724 Escherichia coli Species 0.000 claims description 23
- 241000589341 Methylomonas clara Species 0.000 claims description 20
- 239000013598 vector Substances 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 125000006850 spacer group Chemical group 0.000 claims 1
- 239000012634 fragment Substances 0.000 description 51
- 108020004414 DNA Proteins 0.000 description 47
- 239000000499 gel Substances 0.000 description 26
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 21
- 238000003776 cleavage reaction Methods 0.000 description 21
- 230000007017 scission Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 239000000872 buffer Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000010367 cloning Methods 0.000 description 12
- 238000001962 electrophoresis Methods 0.000 description 10
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 229910001868 water Inorganic materials 0.000 description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 229920000936 Agarose Polymers 0.000 description 8
- 102000003960 Ligases Human genes 0.000 description 8
- 108090000364 Ligases Proteins 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010092681 DNA Primase Proteins 0.000 description 7
- 239000011543 agarose gel Substances 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
- 235000019256 formaldehyde Nutrition 0.000 description 5
- 229940015043 glyoxal Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000002285 radioactive effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000007169 ligase reaction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 241001131785 Escherichia coli HB101 Species 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000012146 running buffer Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000016559 DNA Primase Human genes 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101500006448 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) Endonuclease PI-MboI Proteins 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 241000276498 Pollachius virens Species 0.000 description 2
- 108020004518 RNA Probes Proteins 0.000 description 2
- 239000003391 RNA probe Substances 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000589344 Methylomonas Species 0.000 description 1
- 241000863393 Methylophilus methylotrophus Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 239000013578 denaturing buffer Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000012145 high-salt buffer Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873720834 DE3720834A1 (de) | 1987-06-24 | 1987-06-24 | Promotoren zur expression von fremd-dna in methylotrophen bakterien, deren gewinnung und deren verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO882792D0 NO882792D0 (no) | 1988-06-23 |
| NO882792L true NO882792L (no) | 1988-12-27 |
Family
ID=6330183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO882792A NO882792L (no) | 1987-06-24 | 1988-06-23 | Fremstilling og anvendelse av promotere for ekspresjon avfremmed-dna i metylotrofe bakterier. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0296484A3 (fi) |
| JP (1) | JPS6430588A (fi) |
| KR (1) | KR890000667A (fi) |
| CN (1) | CN1030939A (fi) |
| AU (1) | AU1828388A (fi) |
| DE (1) | DE3720834A1 (fi) |
| DK (1) | DK345688A (fi) |
| FI (1) | FI883005A (fi) |
| IL (1) | IL86849A0 (fi) |
| NO (1) | NO882792L (fi) |
| NZ (1) | NZ225121A (fi) |
| PT (1) | PT87809B (fi) |
| ZA (1) | ZA884486B (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8652820B2 (en) | 2008-11-14 | 2014-02-18 | Fujian Fuda Biotech Co. Ltd. | Thermotolerant Non-K12 Escherichia coli phytase and its production |
| CN104685060B (zh) | 2012-07-13 | 2019-11-01 | 凯利斯塔公司 | 生物精炼系统、其方法和组合物 |
| WO2014047209A1 (en) | 2012-09-18 | 2014-03-27 | Calysta Energy, Inc. | Propylene synthesis using engineered enzymes |
| US10480016B2 (en) | 2012-10-15 | 2019-11-19 | Calysta, Inc. | Genetically engineered microorganisms for biological oxidation of hydrocarbons |
| US9845474B2 (en) | 2012-10-24 | 2017-12-19 | Calysta, Inc. | Engineering of multi-carbon substrate utilization pathways in methanotrophic bacteria |
| WO2014074886A1 (en) | 2012-11-09 | 2014-05-15 | Calysta Energy, Inc. | Compositions and methods for biological production of fatty acid derivatives |
| CN105378077A (zh) | 2013-06-18 | 2016-03-02 | 凯利斯塔公司 | 用于使用乳酸脱氢酶转化体从c1化合物以生物方式产生乳酸的组合物和方法 |
| KR20160107202A (ko) | 2014-01-16 | 2016-09-13 | 칼리스타, 인코포레이티드 | 탄수화물-농축된 재조합 미생물 |
| AU2015206272B2 (en) | 2014-01-16 | 2020-12-03 | Calysta, Inc. | Microorganisms for the enhanced production of amino acids and related methods |
| BR112016026562A2 (pt) | 2014-05-15 | 2017-08-15 | Calysta Inc | Métodos para produção biológica de compostos de cadeia de carbono muito longa |
| WO2020139974A1 (en) | 2018-12-27 | 2020-07-02 | Calysta, Inc. | Glycogen-null methanotrophs and uses thereof |
| KR102123512B1 (ko) * | 2019-03-12 | 2020-06-16 | 한국에너지기술연구원 | 메타노트로프(Methanotroph)에서 유래한 신규 메타노트로프-대장균 셔틀 벡터 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0098967B1 (de) * | 1982-06-11 | 1989-08-09 | Hoechst Aktiengesellschaft | Verfahren zur Herstellung von obligat methylotrophen, Fremd-DNA exprimierenden Bakterien und dafür geeignete Plasmide und Wirtsorganismen |
| DE3635583A1 (de) * | 1986-10-20 | 1988-04-21 | Hoechst Ag | Hybridplasmid zur replikation in methylotrophen mikroorganismen und verfahren zu dessen herstellung |
-
1987
- 1987-06-24 DE DE19873720834 patent/DE3720834A1/de not_active Withdrawn
-
1988
- 1988-06-16 EP EP88109609A patent/EP0296484A3/de not_active Withdrawn
- 1988-06-22 CN CN88103772A patent/CN1030939A/zh active Pending
- 1988-06-22 NZ NZ225121A patent/NZ225121A/xx unknown
- 1988-06-22 FI FI883005A patent/FI883005A/fi not_active Application Discontinuation
- 1988-06-22 KR KR1019880007521A patent/KR890000667A/ko not_active Application Discontinuation
- 1988-06-23 DK DK345688A patent/DK345688A/da not_active Application Discontinuation
- 1988-06-23 AU AU18283/88A patent/AU1828388A/en not_active Abandoned
- 1988-06-23 NO NO882792A patent/NO882792L/no unknown
- 1988-06-23 PT PT87809A patent/PT87809B/pt not_active IP Right Cessation
- 1988-06-23 IL IL86849A patent/IL86849A0/xx unknown
- 1988-06-23 ZA ZA884486A patent/ZA884486B/xx unknown
- 1988-06-24 JP JP63156606A patent/JPS6430588A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3720834A1 (de) | 1989-01-05 |
| IL86849A0 (en) | 1988-11-30 |
| FI883005A0 (fi) | 1988-06-22 |
| JPS6430588A (en) | 1989-02-01 |
| DK345688D0 (da) | 1988-06-23 |
| EP0296484A3 (de) | 1990-01-17 |
| DK345688A (da) | 1988-12-25 |
| AU1828388A (en) | 1989-01-05 |
| FI883005A (fi) | 1988-12-25 |
| PT87809B (pt) | 1992-10-30 |
| PT87809A (pt) | 1989-05-31 |
| CN1030939A (zh) | 1989-02-08 |
| NZ225121A (en) | 1990-08-28 |
| NO882792D0 (no) | 1988-06-23 |
| ZA884486B (en) | 1990-04-25 |
| KR890000667A (ko) | 1989-03-16 |
| EP0296484A2 (de) | 1988-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| El-Sheekh | Stable transformation of the intact cells of Chlorella kessleri with high velocity microprojectiles | |
| Wang et al. | A novel sigma factor is involved in expression of the rpoH gene of Escherichia coli | |
| Gärtner et al. | Expression of the Bacillus subtilis xyl operon is repressed at the level of transcription and is induced by xylose | |
| Rolfes et al. | Escherichia coli gene purR encoding a repressor protein for purine nucleotide synthesis. Cloning, nucleotide sequence, and interaction with the purF operator. | |
| NO882792L (no) | Fremstilling og anvendelse av promotere for ekspresjon avfremmed-dna i metylotrofe bakterier. | |
| Perozzi et al. | RAD7 gene of Saccharomyces cerevisiae: transcripts, nucleotide sequence analysis, and functional relationship between the RAD7 and RAD23 gene products | |
| Federoff et al. | Isolation of a maltase structural gene from Saccharomyces carlsbergensis | |
| Dubnau et al. | Regulation of spo0H, an early sporulation gene in bacilli | |
| Stoner et al. | The araE low affinity L-arabinose transport promoter: cloning, sequence, transcription start site and DNA binding sites of regulatory proteins | |
| Houba-Hérin et al. | Excision of a Ds-like maize transposable element (Ac Δ) in a transient assay in Petunia is enhanced by a truncated coding region of the transposable element Ac | |
| Li et al. | Promoter region of the nar operon of Escherichia coli: nucleotide sequence and transcription initiation signals | |
| Sutherland et al. | Isolation and expression of the Escherichia coli gene encoding malate dehydrogenase | |
| Bohannon et al. | Regulation of Bacillus subtilis glutamate synthase genes by the nitrogen source | |
| Ganduri et al. | TdcA, a transcriptional activator of the tdcABC operon of Escherichia coli, is a member of the LysR family of proteins | |
| Bonnefoy et al. | Presence in the'silent’terminus region of the Escherichia coli K12 chromosome of cryptic gene (s) encoding a new nitrate reductase | |
| Weir et al. | Bacillus subtilis spo0H gene | |
| Dubnau et al. | Cloning of an early sporulation gene in Bacillus subtilis | |
| Kullik et al. | Inhibition of Bradyrhizobium japonicum nifA-dependent nif gene activation by oxygen occurs at the NifA protein level and is irreversible | |
| Morita et al. | Regulatory effect of a synthetic CRP recognition sequence placed downstream of a promoter | |
| Cossart et al. | Construction and expression of a hybrid plasmid containing the Escherichia coli thrA and thrB genes | |
| Ritzenthaler et al. | Use of in vitro gene fusions to study the uxuR regulatory gene in Escherichia coli K-12: direction of transcription and regulation of its expression | |
| Salles et al. | Interaction of the CRP-cAMP complex with the cea regulatory region | |
| Efstathiou et al. | Cloning of Clostridium acetobutylicum genes and their expression in Escherichia coli and Bacillus subtilis | |
| Whitehead et al. | Cloning and expression in Escherichia coli of the gene for 10-formyltetrahydrofolate synthetase from Clostridium acidiurici (" Clostridium acidi-urici") | |
| Brandt | Cloning of double stranded DNA coding for hordein polypeptides |